{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:26:58Z","timestamp":1794860818533,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with vaccine efficacy. Using data from 1,076 participants enrolled in ChAdOx1 nCov-19 vaccine efficacy trials in the United Kingdom, we found that inter-individual variation in normalized antibody responses against SARS-CoV-2 spike and its receptor-binding domain (RBD) at 28\u2009days after first vaccination shows genome-wide significant association with major histocompatibility complex (MHC) class II alleles. The most statistically significant association with higher levels of anti-RBD antibody was HLA-DQB1*06 (<jats:italic>P<\/jats:italic>\u2009=\u20093.2\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>), which we replicated in 1,677 additional vaccinees. Individuals carrying HLA-DQB1*06 alleles were less likely to experience PCR-confirmed breakthrough infection during the ancestral SARS-CoV-2 virus and subsequent Alpha variant waves compared to non-carriers (hazard ratio\u2009=\u20090.63, 0.42\u20130.93, <jats:italic>P<\/jats:italic>\u2009=\u20090.02). We identified a distinct spike-derived peptide that is predicted to bind differentially to HLA-DQB1*06 compared to other similar alleles, and we found evidence of increased spike-specific memory B cell responses in HLA-DQB1*06 carriers at 84\u2009days after first vaccination. Our results demonstrate association of HLA type with Coronavirus Disease 2019 (COVID-19) vaccine antibody response and risk of breakthrough infection, with implications for future vaccine design and implementation.<\/jats:p>","DOI":"10.1038\/s41591-022-02078-6","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T14:03:00Z","timestamp":1665669780000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-2209","authenticated-orcid":false,"given":"Alexander J.","family":"Mentzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-9886","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagida","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-7025","authenticated-orcid":false,"given":"Irina","family":"Chelysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Clutterbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Dinesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7030-7839","authenticated-orcid":false,"given":"Nick J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Felle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-0991","authenticated-orcid":false,"given":"Shuo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6460-1372","authenticated-orcid":false,"given":"Amy L.","family":"Flaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Karp-Tatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1055-0033","authenticated-orcid":false,"given":"Natalie","family":"Marchevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Makinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maireid B.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bana","family":"Alamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Malinauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-2632","authenticated-orcid":false,"given":"Amanda Y.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-6559","authenticated-orcid":false,"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Oxford COVID Vaccine Trial Genetics Study Team Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabella","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktash","family":"Khozoee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brama","family":"Hanumunthadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R. W.","family":"Emary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Cifuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshi N.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair C.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P. J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Toshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeka","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth O.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Darton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Libri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Anslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Provtsgaard-Morys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Adlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-719X","authenticated-orcid":false,"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-5536","authenticated-orcid":false,"given":"Julian C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"2078_CR1","unstructured":"COVID-19 Map. Johns Hopkins Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"o1144","DOI":"10.1136\/bmj.o1144","volume":"377","author":"L Taylor","year":"2022","unstructured":"Taylor, L. Covid-19: true global death toll from pandemic is almost 15 million, says WHO. BMJ 377, o1144 (2022).","journal-title":"BMJ"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"F Polack","year":"2020","unstructured":"Polack, F. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"2078_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41591-021-01410-w","volume":"27","author":"E Pritchard","year":"2021","unstructured":"Pritchard, E. et al. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat. Med. 27, 1370\u20131378 (2021).","journal-title":"Nat. Med."},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal, J. et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 385, 585\u2013594 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2078_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","volume":"397","author":"E Vasileiou","year":"2021","unstructured":"Vasileiou, E. et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet 397, 1646\u20131657 (2021).","journal-title":"Lancet"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","volume":"385","author":"M Bergwerk","year":"2021","unstructured":"Bergwerk, M. et al. Covid-19 breakthrough infections in vaccinated health care workers. N. Engl. J. Med. 385, 1474\u20131484 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"Y Bar-On","year":"2021","unstructured":"Bar-On, Y. et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N. Engl. J. Med. 385, 1393\u20131400 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2078_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","volume":"6","author":"J Wei","year":"2021","unstructured":"Wei, J. et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat. Microbiol. 6, 1140\u20131149 (2021).","journal-title":"Nat. Microbiol."},{"key":"2078_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1126\/science.abe2402","volume":"370","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science 370, 1110\u20131115 (2020).","journal-title":"Science"},{"key":"2078_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"D Khoury","year":"2021","unstructured":"Khoury, D. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"2078_CR13","unstructured":"Feng, S. et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat. Med. 27, 2032\u20132040 (2021)."},{"key":"2078_CR14","doi-asserted-by":"crossref","unstructured":"Collier, D. A. et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 596, 417\u2013422 (2021).","DOI":"10.1038\/s41586-021-03739-1"},{"key":"2078_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.gene.6364051","volume":"5","author":"MJ Newport","year":"2004","unstructured":"Newport, M. J. et al. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 5, 122\u2013129 (2004).","journal-title":"Genes Immun."},{"key":"2078_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1568-9972(03)00031-4","volume":"2","author":"DR Milich","year":"2003","unstructured":"Milich, D. R. & Leroux-Roels, G. G. Immunogenetics of the response to HBsAg vaccination. Autoimmun. Rev. 2, 248\u2013257 (2003).","journal-title":"Autoimmun. Rev."},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1093\/hmg\/ddr302","volume":"20","author":"E Png","year":"2011","unstructured":"Png, E. et al. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum. Mol. Genet. 20, 3893\u20133898 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"2078_CR18","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fgene.2019.00696","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Host genetic determinants of hepatitis B virus infection. Front. Genet. 10, 696 (2019).","journal-title":"Front. Genet."},{"key":"2078_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/hep.29876","volume":"68","author":"N Nishida","year":"2018","unstructured":"Nishida, N. et al. Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology 68, 848\u2013858 (2018).","journal-title":"Hepatology"},{"key":"2078_CR20","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1016\/j.celrep.2019.05.053","volume":"27","author":"D O\u2019Connor","year":"2019","unstructured":"O\u2019Connor, D. et al. Common genetic variations associated with the persistence of immunity following childhood immunization. Cell Rep. 27, 3241\u20133253 (2019).","journal-title":"Cell Rep."},{"key":"2078_CR21","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.vaccine.2012.01.038","volume":"30","author":"IG Ovsyannikova","year":"2012","unstructured":"Ovsyannikova, I. G., Pankratz, V. S., Vierkant, R. A., Jacobson, R. M. & Poland, G. A. Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine 30, 2146\u20132152 (2012).","journal-title":"Vaccine"},{"key":"2078_CR22","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1016\/j.vaccine.2012.07.063","volume":"30","author":"HD Clifford","year":"2012","unstructured":"Clifford, H. D. et al. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine 30, 6180\u20136185 (2012).","journal-title":"Vaccine"},{"key":"2078_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1440-1746.2001.02530.x","volume":"16","author":"T Suzuki","year":"2001","unstructured":"Suzuki, T., Yamauchi, K., Kuwata, T. & Hayashi, N. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders. J. Gastroenterol. Hepatol. 16, 898\u2013903 (2001).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2078_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0168-8278(02)00205-2","volume":"37","author":"T Hohler","year":"2002","unstructured":"Hohler, T. et al. C4A deficiency and nonresponse to hepatitis B vaccination. J. Hepatol. 37, 387\u2013392 (2002).","journal-title":"J. Hepatol."},{"key":"2078_CR25","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 600, 472\u2013477 (2021)."},{"key":"2078_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-022-04576-6","volume":"607","author":"A Kousathanas","year":"2022","unstructured":"Kousathanas, A. et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature 607, 97\u2013103 (2022).","journal-title":"Nature"},{"key":"2078_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2020","unstructured":"Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in COVID-19. Nature 591, 92\u201398 (2020).","journal-title":"Nature"},{"key":"2078_CR28","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonzalez-Galarza","year":"2015","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43, D784\u2013D788 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2078_CR29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1073\/pnas.0308458100","volume":"101","author":"C Siebold","year":"2004","unstructured":"Siebold, C. et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc. Natl Acad. Sci. USA 101, 1999\u20132004 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2078_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"2078_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","volume":"136","author":"IH Haralambieva","year":"2017","unstructured":"Haralambieva, I. H. et al. Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. Hum. Genet. 136, 421\u2013435 (2017).","journal-title":"Hum. Genet."},{"key":"2078_CR32","doi-asserted-by":"crossref","unstructured":"Milne, G. et al. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? Lancet Respir. Med. 9, 1450\u20131466 (2021).","DOI":"10.1016\/S2213-2600(21)00407-0"},{"key":"2078_CR33","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 48, D783\u2013D788 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2078_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/tan.13811","volume":"95","author":"C Hurley","year":"2020","unstructured":"Hurley, C. et al. Common, intermediate and well-documented HLA alleles in world populations: CIWD version 3.0.0. HLA 95, 516\u2013531 (2020).","journal-title":"HLA"},{"key":"2078_CR35","doi-asserted-by":"crossref","unstructured":"Hammer, C. et al. Amino acid variation in HLA class II proteins is a major determinant of humoral response to common viruses. Am. J. Hum. Genet. 97, 738\u2013743 (2015).","DOI":"10.1016\/j.ajhg.2015.09.008"},{"key":"2078_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou, C. A., Petersen, J., Rossjohn, J. & Fugger, L. HLA variation and disease. Nat. Rev. Immunol. 18, 325\u2013339 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2078_CR37","doi-asserted-by":"crossref","unstructured":"Nishida, N. et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci. Rep. 11, 3703 (2021).","DOI":"10.1038\/s41598-021-82986-8"},{"key":"2078_CR38","doi-asserted-by":"crossref","unstructured":"Somogyi, E. et al. A peptide vaccine candidate tailored to individuals\u2019 genetics mimics the multi-targeted T cell immunity of COVID-19 convalescent subjects. Front. Genet. 12, 684152 (2021).","DOI":"10.3389\/fgene.2021.684152"},{"key":"2078_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","volume":"14","author":"J Trowsdale","year":"2013","unstructured":"Trowsdale, J. & Knight, J. C. Major histocompatibility complex genomics and human disease. Annu. Rev. Genomics Hum. Genet. 14, 301\u2013323 (2013).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2078_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet 396, 467\u2013478 (2020).","journal-title":"Lancet"},{"key":"2078_CR41","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(22)00770-X","volume":"399","author":"G Li","year":"2022","unstructured":"Li, G. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6\u201317 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Lancet 399, 2212\u20132225 (2022).","journal-title":"Lancet"},{"key":"2078_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(21)02718-5","volume":"399","author":"ASV Stuart","year":"2022","unstructured":"Stuart, A. S. V. et al. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet 399, 36\u201349 (2022).","journal-title":"Lancet"},{"key":"2078_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","volume":"398","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet 398, 856\u2013869 (2021).","journal-title":"Lancet"},{"key":"2078_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"2078_CR45","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279\u20131283 (2016).","journal-title":"Nat. Genet."},{"key":"2078_CR46","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41588-021-00935-7","volume":"53","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nat. Genet. 53, 1504\u20131516 (2021).","journal-title":"Nat. Genet."},{"key":"2078_CR47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens, M., Smith, N. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978\u2013989 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"2078_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"2078_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.imbio.2012.05.008","volume":"218","author":"J Tr\u00fcck","year":"2013","unstructured":"Tr\u00fcck, J. et al. The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans. Immunobiology 218, 368\u2013372 (2013).","journal-title":"Immunobiology"},{"key":"2078_CR50","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1128\/CVI.00336-07","volume":"15","author":"EA Clutterbuck","year":"2008","unstructured":"Clutterbuck, E. A. et al. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin. Vaccin. Immunol. 15, 182\u2013193 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"2078_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76\u201382 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"2078_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i02","volume":"36","author":"MP Fay","year":"2010","unstructured":"Fay, M. P. & Shaw, P. A. Exact and asymptotic weighted logrank tests for interval censored data: the interval R package. J. Stat. Softw. 36, 1\u201334 (2010).","journal-title":"J. Stat. Softw."},{"key":"2078_CR53","unstructured":"Therneau, T. M. & Grambsch, P. M. A Package for Survival Analysis in S (Mayo Foundation, 1999); https:\/\/www.mayo.edu\/research\/documents\/tr53pdf\/doc-10027379"},{"key":"2078_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v043.i13","volume":"43","author":"WM van der Wal","year":"2011","unstructured":"van der Wal, W. M. & Geskus, R. B. ipw: an R package for inverse probability weighting. J. Stat. Softw. 43, 1\u201323 (2011).","journal-title":"J. Stat. Softw."},{"key":"2078_CR55","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/bioinformatics\/btm108","volume":"23","author":"YS Aulchenko","year":"2007","unstructured":"Aulchenko, Y. S., Ripke, S., Isaacs, A. & van Duijn, C. M. GenABEL: an R library for genome-wide association analysis. Bioinformatics 23, 1294\u20131296 (2007).","journal-title":"Bioinformatics"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02078-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T17:05:36Z","timestamp":1674579936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02078-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-02078-6","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Oxford has entered into a partnership with AstraZeneca for further development of ChAdOx1 nCoV-19. T.L. is named as an inventor on a patent application covering this SARS-CoV-2 vaccine and was a consultant to Vaccitech for an unrelated project. A.J.P. is Chair of the UK Department of Health and Social Care (DHSC) Joint Committee on Vaccination & Immunisation (JCVI) but does not participate in discussions on COVID-19 vaccines and is a member of the Strategic Advisory Group of Experts on Immunization to the World Health Organization (WHO). A.J.P. is an NIHR senior investigator. The remaining authors declare no competing interests. The views expressed in this article do not necessarily represent the views of the DHSC, JCVI, NIHR or WHO.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}